ArticleEClinicalMedicine2026

Corrigendum to "Obinutuzumab induction and maintenance in patients with Waldenström macroglobulinaemia: an open-label, single-arm phase 2 study" EClinicalMedicine. 2025 Jul 25:86:103383.

Tomasz Wróbel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.